@Article{Pietrzak2021,
journal="Pediatric Endocrinology Diabetes and Metabolism",
issn="2081-237X",
volume="27",
number="4",
year="2021",
title="Ultrafast acting insulin analog – a new way to prevent postprandial hyperglycemia and improve quality of life in type 1 diabetes patients – case reports",
abstract="The aim of modern insulin therapy used in the treatment of type 1 diabetes mellitus is to mimic the physiological secretion of insulin in order to ensure stable normoglycemia while maintaining the greatest possible comfort of life for diabetic patients. New ultra-fast insulin analogs that can be administered immediately before a meal contribute to the improvement of postprandial glycemia and the quality of life of patients. We presented two cases illustrating the effectiveness and safety of the use of an ultra-fast-acting insulin analog in the treatment of postprandial hyperglycemia in children with type 1 diabetes.",
author="Pietrzak, Iwona
and Szadkowska, Agnieszka",
pages="305--310",
doi="10.5114/pedm.2022.112621",
url="http://dx.doi.org/10.5114/pedm.2022.112621"
}